Previously Treated Childhood Rhabdomyosarcoma Completed Phase 2 Trials for Trabectedin (DB05109)

IndicationStatusPhase
DBCOND0028747 (Previously Treated Childhood Rhabdomyosarcoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070109Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of TumorsTreatment